Gavi and Bavarian Nordic Accelerate Mpox Vaccine Supply to Africa

Wednesday, 18 September 2024, 11:52

Mpox vaccine agreement announced today by Gavi and Bavarian Nordic aims to deliver 500,000 Jynneos doses to African countries this year. This strategic partnership is set to enhance vaccine availability amid rising health concerns. The initiative represents a significant commitment to public health and vaccine equity.
Cidrap
Gavi and Bavarian Nordic Accelerate Mpox Vaccine Supply to Africa

Gavi and Bavarian Nordic Forge Agreement

Gavi, the Vaccine Alliance, and Bavarian Nordic are taking important steps to address the mpox public health crisis. In a recent breakthrough, these organizations announced an advanced purchase agreement to secure 500,000 doses of the Jynneos mpox vaccine.

Impact on African Countries

The doses are scheduled for delivery this year. This initiative is crucial for enhancing vaccine access, especially in regions that face significant health challenges. As the mpox virus poses serious health risks, prompt access to vaccines is essential.

Through this agreement, Gavi and Bavarian Nordic are setting a precedent for future vaccine collaborations, emphasizing the importance of equitable healthcare solutions.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe